Dermapharm Holding SE
DMPHF
$38.50
-$2.12-5.23%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 29.15% | 80.85% | 83.86% | -1.90% | -28.72% |
| Total Depreciation and Amortization | 27.62% | -8.30% | 5.52% | -10.59% | -41.27% |
| Total Amortization of Deferred Charges | -18.02% | -18.02% | -18.02% | 99.76% | 99.76% |
| Total Other Non-Cash Items | -18.74% | -71.21% | -55.67% | -66.52% | -61.59% |
| Change in Net Operating Assets | 167.62% | -74.01% | -306.34% | -269.63% | -173.79% |
| Cash from Operations | 16.76% | -3.63% | -7.95% | -27.20% | -35.51% |
| Capital Expenditure | 3.18% | 1.81% | 8.16% | -3.46% | -16.19% |
| Sale of Property, Plant, and Equipment | -87.26% | 37.04% | 34.49% | 1,035.19% | 1,103.29% |
| Cash Acquisitions | -- | -- | -- | 100.00% | 100.45% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -64.73% | -61.02% | -62.04% | 5,411.42% | 399.29% |
| Cash from Investing | -99.77% | -31.79% | 92.82% | 95.06% | 96.07% |
| Total Debt Issued | 1.30% | 124.88% | -84.45% | -90.97% | -91.87% |
| Total Debt Repaid | -7.17% | 10.67% | 47.89% | 80.38% | 82.27% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | 15.35% | 15.35% | 15.35% | 100.00% |
| Other Financing Activities | -20.32% | -10.04% | -62.25% | -60.53% | -177.99% |
| Cash from Financing | -58.83% | 42.89% | -205.08% | -227.57% | -170.96% |
| Foreign Exchange rate Adjustments | -1,219.87% | -466.21% | -1,389.80% | -53.90% | 79.22% |
| Miscellaneous Cash Flow Adjustments | -- | 99.76% | 100.12% | 100.00% | 100.00% |
| Net Change in Cash | -102.53% | 96.82% | -707.07% | 96.88% | 124.35% |